2nd Generation Oligo Fucoidan
Translab
Oligo Fucoidan EX, FOII ®
“NEW TECHNOLOGY UPGRADED"
FOII® Oligo Fucoidan is a patented high water soluble carrier technology, active ingredient with multiple health benefits.
The 2nd generation low molecular weight fucoidan (<500-3000Da), a new manufacturing processes has increased the bioactivity by 2-3 times; derived from naturally dried, oceanic brown seaweed (Saccharina japonica) as functional food health ingredient. It is water soluble, standardized spray dried brown seaweed polysaccharide extract. It is a light brown powder with characteristic taste and no od or.
Translab FOII®Oligo Fucoidan is completed human clinical trials with remarkable results.
It is marketed under the trademark FOII® or Translab FOII® Oligo Fucoidan EX.
- Water hydrolysis fucoidan 3 times more bioactive than 1 st generation
- 99% high concentration water soluble fucoidan
- Patented technology Highly water soluble coating technology
- 2 nd Generation polymer structure : Completely soluble, fully release, high absorption
Oligon-Fucoidan
(Low Molecular Weight)
- Small size
- Increase the contact area
- Regulate physiological functions increased above 40%
Increase the contact area
Regulate physiological functions
Porousand high permeability
High solubility, 99%
Ultra-pressure filtration
Remove invalid sediment
Normal Fucoidan
(High Molecular Weight)
- Big size
- Cannot fully bind to the receptor
- Low physiological function
2nd generation Oligo Fucoidan Highly Water-Soluble Carrier Technology
- Exclusive patented technology
- High safety
- Water soluble
- Hydrolysis extraction technology
- Ultra-pressure filtration
- Porous and high permeability
- Activity increased by 300%
HEALTH BENEFITS & CLINICAL APPLICATION
Bi-directional immune regulation and anti-inflammation
Improve autoimmune diseases with excessive TH1
Rheumatoid arthritis, psoriasis, chronic disease viral infection and etc.
Improve autoimmune diseases with excessive TH2
Lupus erythematosus, atopic dermatitis, allergic dermatitis, sinusitis, allergies, asthma and etc.
Anti-inflammatory
Acute inflammation and chronic inflammation in various parts of the body (such as mycoplasma pneumonia, stomatitis, gastroenteritis, pancreatitis)
CANCER ADJUVANT TREATMENT
Before treatment
- Induces cancer cell apoptosis
- Inhibit cancer angiogenesis
- Tumor size and metastasis control
Treatment
- Improve disease control rate by 92.8%
- Reduce the side effects of chemotherapy and radiotherapy
- Additive effect, radiotherapy effect
After treatment
- Prevent cancer formation and recurrence
Manufacturing process –
breakthrough 1st vs 2nd generation oligo fucoidan
